D-0558-2022 Class II Terminated

Recalled by Lannett Company, Inc. — Philadelphia, PA

FDA drug recall D-0558-2022 was initiated by Lannett Company, Inc. on Feb 9, 2022 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification results for related substances. The recall status is terminated (terminated May 1, 2023). Affected quantity: 23,598 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 23, 2022
Initiation Date
Feb 9, 2022
Termination Date
May 1, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,598 bottles

Product description

Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1768-36.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification results for related substances.

Distribution pattern

Product was distributed nationwide in the USA.

Code information

Lot #: 2664A, 2664B, Exp. date 07/2022; 2874A, 2874B, Exp. date 01/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0558-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0558-2022. Report a data issue: hello@regdatalab.com.